Go directly to MassDevice. Having trouble reading this email? View this newsletter in your browser here.
Not interested? Unsubscribe.
Weekly Roundup
Smith & Nephew wins a round in wound-care war; healthcare in the crosshairs; Stryker not a big spender; medical device tax halved
Go directly to MassDevice. Having trouble reading this email? View this newsletter in your browser here.
Not interested? Unsubscribe.
Thermo Fisher joins the re-fi boom
Go directly to MassDevice. Having trouble reading this email? View this newsletter in your browser here.
Not interested? Unsubscribe.
EXCLUSIVE: FDA lags on 510(k) clearances
Go directly to MassDevice. Having trouble reading this email? View this newsletter in your browser here.
Not interested? Unsubscribe.
Eye on the FDA
Go directly to MassDevice. Having trouble reading this email? View this newsletter in your browser here.
Not interested? Unsubscribe.
Insulet’s Q3 sales
Go directly to MassDevice. Having trouble reading this email? View this newsletter in your browser here.
Not interested? Unsubscribe.
Boston Scientific records a $200 million third-quarter profit
Go directly to MassDevice. Having trouble reading this email? View this newsletter in your browser here.
Not interested? Unsubscribe.
Medical device industry news from MassDevice.com: October 14, 2009
Go directly to MassDevice. Having trouble reading this email? View this newsletter in your browser here.
Not interested? Unsubscribe.
Device industry to Baucus: How about $15 billion instead?
Go directly to MassDevice. Having trouble reading this email? View this newsletter in your browser here.
Not interested? Unsubscribe.
Covidien to drop $210 million for Aspect Medical Systems
Go directly to MassDevice. Having trouble reading this email? View this newsletter in your browser here.
Not interested? Unsubscribe.
Medtronic: Endeavor stent is safer than BoSci’s Taxus
Go directly to MassDevice. Having trouble reading this email? View this newsletter in your browser here.
Not interested? Unsubscribe.